IPRO
Imaging-based prognostication AI endpoint for oncology trials
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
IPRO is Altis Labs' flagship AI endpoint that predicts patient outcomes from routinely acquired radiology CT scans. It automatically generates survival predictions and Spatial Imaging Biomarkers so biopharma sponsors can detect treatment effects earlier than conventional imaging endpoints such as objective response rate. Used to analyze phase 1–4 oncology trial imaging data.
- Website
- altislabs.com/product
- Added via
- web
- Ownership
- unclaimed
Where to go
Product details
- Product kind
- Saas